GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » YoY EBITDA Growth

Vicplas International (SGX:569) YoY EBITDA Growth : -38.46% (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vicplas International's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was -38.46%.

Vicplas International's EBITDA per Share for the six months ended in Jan. 2024 was S$0.01.


Vicplas International YoY EBITDA Growth Historical Data

The historical data trend for Vicplas International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International YoY EBITDA Growth Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.33 62.50 42.31 -5.41 -28.57

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -5.56 -27.78 -29.41 -38.46

Vicplas International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vicplas International's YoY EBITDA Growth for the fiscal year that ended in Jul. 2023 is calculated as:

YoY EBITDA Growth (A: Jul. 2023 )
=(EBITDA per Share (A: Jul. 2023 )-EBITDA per Share (A: Jul. 2022 ))/ | EBITDA per Share (A: Jul. 2022 ) |
=(0.025-0.035)/ | 0.035 |
=-28.57 %

Vicplas International's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Jan. 2023 )) / | EBITDA per Share (Q: Jan. 2023 )) |
=(0.008-0.013)/ | 0.013 |
=-38.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicplas International YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vicplas International's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines